Chip Stock Investor on $RKLB (Nov 12, 2026)
Rocket Lab stays on watch and is not a buy: record Q3 2026 revenue/backlog and a path toward a $2 billion business with Iridium are offset by a nearly $40 billion market cap, 25% share count growth and more Iridium dilution, plus debt refinancing that may need more stock. Neutron is delayed to 2027 and markets may already price Neutron/Iridium benefits, risking post-catalyst volatility; no good entry since March 2025, and they passed on the forty-four dollar dip.
Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy
Jump to any passage
Let's revisit Rocket Lab, the company that we have done a public video on a few times since early 2025, before the tariff tantrum. And, this report was gonna be an important one we knew because the company had already delayed the highly anticipated Neutron first launch into 2027.
Rocket Lab Q3 2026 earnings. Record revenue, record backlog. Yes, the Neutron first launch moves to 2027, sometime in 2027.
The Iridium deal is now funded with an additional stock sale that Rocket Lab made last quarter. We think that's a pretty good move, using the elevated stock price to get that cash that they need.
When Rocket Lab finalizes the Iridium communications deal, they will be an end-to-end space economy stock like SpaceX.
Of course, there at the bottom, they make components. They've brought a lot of that in-house. They provide a lot of their own software and operating systems. And of course, now they provide launch services.
They're the infrastructure layer there in the middle, not just building space vehicles, but also launch services as well primarily with the Electron rocket. And now products and services there at the top.
And here is a look at Rocket Lab's current revenue composition. They're on the bar on the far right, 268 million in total revenue in Q3 2026, up from just a 155 million a year ago in Q3 2025.
Space Systems is still at this point the majority of sales. It was up 88 percent year over year to nearly 215 million. Launch services, a lumpier part of the revenue. You can see the purple bars there have been a bigger piece of the pie in Q4 2025 and Q1 2026 in particular.
But Launch Services revenue still up thirty percent year over year to 53 million.
Here's a slide from Rocket Lab itself showing their space systems and their launch revenue over the last five years, 2020 through 2025, and the expected full year revenue guide for 2026 at the high end of guidance, 992 million.
So let's call it a billion dollars. Very possible Rocket Lab could hit its first one billion revenue year in 2026.
And on the right-hand side, check out that gross margin growth. On an adjusted gross margin basis, negative 29% still in 2020, but that has improved to an expected almost 41% for full year 2026.
Unadjusted GAAP gross margin for 2026 is expected to be a little over 35%.
So Rocket Lab growing at an incredible pace, making great progress on profitability and, those gross margins, as we've talked about in past videos, really exceptional for an aerospace and defense company.
Many of the old incumbents, the old peers in the economy, if they're doing mid-teens, even the 20% range gross margin, they're doing really well. Rocket Lab, beating that average with vertical integration, next gen technology, and being able to charge for that next gen technology, spanning both the space systems and the launch services and related infrastructure.
Here's a look at their backlog, which is now almost three point six billion, over three times what it was just a year ago. And up 52% quarter over quarter. Pretty incredible, and you can see the skew already.
Space Systems backlog at the end of Q3 2026 actually fell below half of what the total is, and Launch Services now just over half of the total backlog.
What is driving that? That is being primarily driven by the current rocket technology Rocket Lab can actually offer its customers Electron. That is a small lift rocket. There's no comparable version to that at SpaceX.
These are for small payloads, and one of the big orders in Q3 2026 was from Synspective, a small space company in Japan launching its radar data collection, uses infrared to monitor the Earth's surface, its constellation into orbit.
That's one of Rocket Lab's bigger customers, and then there's also the HASTE systems, Hypersonic Accelerator Sub-Orbital Test Electron. That is quite the mouthful. HASTE actually uses the first and second stage of the launch from Electron, and then a third stage for suborbital payload deployment and for high-speed testing.
The long and the short here from this slide, it is Electron that is driving most of the results, and there have been some launch contracts already signed for Neutron. And because it's a larger rocket, the Neutron will compare much more closely to SpaceX's workhorse Falcon 9 medium-lift rocket.
There is going to be much more revenue that they'll be able to realize for those when those begin their missions sometime in 2027.
So, 3.6 billion in total backlog, about a third of that will be realized as revenue over the course of the next 12 months, and hopefully Neutron will start kicking in to some of that realized revenue next year.
But as I said, it is currently the manufacturer of spacecraft that is the driving force here. Over 55 spacecraft in development and production right now, including for Globalstar, which is being acquired by Amazon, also MDA Space, a sizable customer.
And then a bit further out after Iridium is integrated into the mix, we'll have the communications and data services part of the business as well.
So great stuff happening at Rocket Lab. It was a really good quarter, but there are some additional things that we need to consider that have a bearing on investing in this company right now, and we should take a look at the balance sheet because a fair amount of cash, in addition to new Rocket Lab stock, is going to need to be issued to pay for Iridium.
So Rocket Lab did issue some new shares in Q3 2026 to bump up the amount of cash. They now have 4.6 billion in cash and equivalents. More than doubled the amount of cash they had through that stock sale.
That now means paired with the other acquisition activity that has happened in the last 12 months, total shares outstanding have increased 25% year over year at the end of Q3. Do bear that in mind.
Dilution is a serious thing to consider right now because it does offset the amount of revenue growth that is attributable to you, a shareholder or a potential shareholder.
At any rate, this is probably going to be a pretty good use of the cash from that stock issuance. Nearly three billion will go to the cash payment portion of Iridium Communications.
That will go to shareholders of that company, plus some additional stock that will get issued as well that you can see on this slide. So more dilution is coming, but what does the company get in exchange for that?
And so that will greatly help Rocket Lab's margins and help pay for all of the expenses that they have as they ramp up production of different components and component manufacturing they've brought in-house, manufacture of spacecraft, as well as new launch services like Neutron.
In Q3 2026, bottom line there, Rocket Lab's GAAP operating loss was negative 79 million. Again on revenue of $268 million.
Before we jump to that and work that into longer term assumptions for Rocket Lab, take a look at the Q4 2026 guidance, 270 to 290 million in revenue. GAAP gross margin should increase to 35 percent at the midpoint, especially as one of the more recent acquisitions, Mynaric, they get its gross margins up to par with the rest of the business.
So what does this mean for the valuation on Rocket Lab after we have this Q4 2026 and full year 2026 guidance? Well, because Rocket Lab is not currently profitable, it's pretty difficult to run a reverse DCF, but we could start at close to 0% free cash flow margin, assuming the Iridium deal is finalized.
So there on the left, we have the pro forma companies like we talked about last video, Rocket Lab plus Iridium as if they were already one company. On the right-hand side, our longer-term model assumptions, starting revenue at $1.9 billion, starting free cash flow margin combined on a trailing 12-month basis is -2.7%.
Let's call it 0% for our purposes here. And then after 10 years, let's assume they can reach 25% free cash flow profit margin at a discount rate of 10% and a terminal growth rate of 3% thereafter. Gets the stock to a fair value today.
So some of the things that we are watching for right now, that would help sway us to make, a purchase, well besides valuation, we still have a price target in the high forties range.
We decided not to purchase on the last dip. Rocket Lab had fallen all the way to forty-four dollars per share.
We think there are a number of things that could cause some downward pressure on the stock price over the course of the next year or two. First, the Neutron flight. It's very clear, especially after Neutron was announced to be delayed again into 2027, the stock started to fall at that point, and then you add in all of the market volatility that we had late October through beginning of November.
We think that there is some potential here where the market is already pricing in the positive effects of both Neutron and now the Iridium integration. So after those happen and that positive catalyst has been removed, we could start to see some volatility as Rocket Lab needs to manage the integration of those assets into the rest of the operation.
So gross margin will benefit. The Mynaric acquisition. They're pulling those gross margins up so that it meets that mid 30% range for the business. But along the way, there is all this dilution as well.
Just 25% increase in the last year alone. That should start to slow down, especially once the Iridium deal is completed. But in addition to that, we do have some debt that is going to need to be refinanced as well.
The free cash flow alone isn't going to handle that. So how does that get handled? Does Rocket Lab issue more stock? We have some questions there, and we think this should be more of a factor baked into the current stock price, and it doesn't seem to be at this point.
And then finally, the conversion of the backlog into revenue, a third of that converting in the next 12 months over a billion dollars. That's great. That should mean 2027 is another year of fantastic growth for Rocket Lab.
You add in the Iridium deal, we're headed towards a $2 billion a year business. But as you can see from the market cap, still at nearly $40 billion market cap for Rocket Lab, it's priced pretty richly.
So in conclusion, this is why Rocket Lab continues to be on watch for us. We're big believers in the space economy, as well as other areas of high tech development like quantum computing being future drivers of economic growth.
But currently in the 2020s, this is all about GPUs, accelerated computing, AI data center assets, disruption of traditional software by AI, and embedding those across the entire economy.
All of that is currently the main driver of economic growth. And so Rocket Lab, we haven't seen a good enough entry point since March 2025 to go ahead and nibble.
But at this point, we're still just being patient with Rocket Lab. We'll continue keeping it on watch, and so stay tuned for more.